Novel PET imaging methods for prostate cancer

Esther Mena, Peter C. Black, Soroush Rais-Bahrami, Michael Gorin, Mohamad Allaf, Peter Choyke

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Prostate cancer is a common neoplasm but conventional imaging methods such as CT and bone scan are often insensitive. A new class of PET agents have emerged to diagnose and manage prostate cancer. Methods: The relevant literature on PET imaging agents for prostate cancer was reviewed. Results: This review shows a broad range of PET imaging agents, the most successful of which is prostate specific membrane antigen (PSMA) PET. Other agents either lack the sensitivity or specificity of PSMA PET. Conclusion: Among the available PET agents for prostate cancer, PSMA PET has emerged as the leader. It is likely to have great impact on the diagnosis, staging and management of prostate cancer patients.

Original languageEnglish (US)
Pages (from-to)687-699
Number of pages13
JournalWorld journal of urology
Volume39
Issue number3
DOIs
StatePublished - Mar 2021

Keywords

  • Biochemical recurrence
  • Molecular imaging
  • Prostate cancer
  • Prostate-specific membrane antigen
  • Staging

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Novel PET imaging methods for prostate cancer'. Together they form a unique fingerprint.

Cite this